Publication | Open Access

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

Checkmate 142MedicineColorectal CancerPathologyCancer GenomicsCancer TreatmentCancer GeneticsPhase 2OncologyRadiation OncologyInstability-high Colorectal Cancer